Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Unigene Labs Adds CFO | Contract Pharma
Breaking News, Promotions & Moves

Unigene Labs Adds CFO

Moskowitz to lead the strategic direction of financial and capital markets activities

David Moskowitz has been appointed chief financial officer at Unigene Laboratories, Inc. In this newly created position, Mr. Moskowitz will serve as a member of the company’s executive leadership team and lead the strategic direction of the company’s financial and capital markets activities.

Mr. Moskowitz spent the past 13 years as an equity research analyst covering large-cap pharmaceutical, specialty pharmaceutical, biotechnology, and generic drug companies. Most recently, Mr. Moskowitz served as a senior pharmaceutical analyst for Roth Capital Partners, LLC, where he developed research coverage of emerging specialty pharma and biotechnology companies.

Ashleigh Palmer, president and chief executive officer of Unigene, said, “We are extremely excited to welcome David to Unigene and look forward to benefiting from his in-depth knowledge of the pharmaceutical market space, strategic financial perspective, industry and Wall Street network, and strong credibility and reputation within the investment community. In executing Unigene’s turnaround strategy, we recognized the appointment of a chief financial officer would be a critical step in accelerating the next phase of our growth and addressing the priority challenge for Unigene in 2012, our substantial debt. I have no doubt whatsoever that David is the individual we have been searching for.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters